Contributors |
|
xi | |
|
|
xiii | |
|
SECTION 1 What is heart failure? |
|
|
|
|
3 | (6) |
|
|
2 Heart failure syndromes |
|
|
9 | (20) |
|
|
|
|
3 The epidemiology of heart failure |
|
|
29 | (12) |
|
|
|
SECTION 3 The aetiology of heart failure |
|
|
|
4 The classical causes of heart failure |
|
|
41 | (10) |
|
|
|
5 The genetics of heart failure |
|
|
51 | (20) |
|
|
|
6 Metabolic disorders and heart failure |
|
|
71 | (16) |
|
|
7 Heart failure in congenital heart disease |
|
|
87 | (14) |
|
|
|
8 Infective and infiltrative causes of heart failure |
|
|
101 | (18) |
|
|
|
|
|
119 | (14) |
|
|
10 Acute viral myocarditis |
|
|
133 | (6) |
|
|
11 Iatrogenic heart failure |
|
|
139 | (22) |
|
|
|
12 Peripartum cardiomyopathy |
|
|
161 | (6) |
|
|
|
|
|
167 | (14) |
|
|
SECTION 4 Pathophysiology of heart failure: cellular and molecular changes |
|
|
|
14 The pathophysiology of heart failure |
|
|
181 | (12) |
|
|
|
15 Cytokines and inflammatory markers |
|
|
193 | (16) |
|
|
|
|
|
|
209 | (8) |
|
|
|
|
|
217 | (8) |
|
|
|
18 The failing cardiomyocyte |
|
|
225 | (14) |
|
|
|
|
19 The interstitium and collagen in heart failure |
|
|
239 | (8) |
|
|
|
20 Natriuretic peptides and novel biomarkers in heart failure |
|
|
247 | (16) |
|
|
SECTION 5 Diagnosis of heart failure |
|
|
|
21 Diagnosing heart failure |
|
|
263 | (8) |
|
|
|
SECTION 6 Non-invasive investigation |
|
|
|
22 Basic investigation of heart failure |
|
|
271 | (12) |
|
|
|
|
283 | (20) |
|
|
24 Nuclear medicine in heart failure |
|
|
303 | (12) |
|
|
|
25 Cardiovascular magnetic resonance in heart failure |
|
|
315 | (8) |
|
|
|
26 Computed tomography imaging techniques |
|
|
323 | (10) |
|
|
|
|
|
27 Cardiopulmonary exercise testing in chronic heart failure |
|
|
333 | (18) |
|
|
|
SECTION 7 Invasive investigation |
|
|
|
28 Invasive investigation |
|
|
351 | (18) |
|
|
|
SECTION 8 Prognostication |
|
|
|
|
369 | (20) |
|
|
|
SECTION 9 Co-morbidities: the patient with heart failure and |
|
|
|
30 Heart failure with preserved ejection fraction: pathophysiology and treatment |
|
|
389 | (12) |
|
|
|
|
401 | (10) |
|
|
32 Anaemia and iron deficiency |
|
|
411 | (10) |
|
|
|
|
421 | (12) |
|
|
|
|
433 | (12) |
|
|
|
|
|
35 Pulmonary hypertension |
|
|
445 | (16) |
|
|
|
461 | (14) |
|
|
37 Valvular heart disease |
|
|
475 | (10) |
|
|
|
38 Sleep-disordered breathing |
|
|
485 | (10) |
|
|
|
495 | (12) |
|
|
|
|
507 | (18) |
|
|
|
|
525 | (10) |
|
|
|
42 Anxiety and depression |
|
|
535 | (10) |
|
|
|
|
545 | (12) |
|
|
|
SECTION 10 Treatment of acute heart failure |
|
|
|
44 Inotropes, pressors, and vasodilators |
|
|
557 | (10) |
|
|
|
|
567 | (12) |
|
|
|
|
579 | (8) |
|
|
|
47 Therapeutic control of fluid balance in chronic heart failure |
|
|
587 | (20) |
|
|
|
|
SECTION 11 Medical therapy for chronic heart failure |
|
|
|
48 Angiotensin converting enzyme inhibitors and vasodilators |
|
|
607 | (10) |
|
|
|
49 Angiotensin receptor blockers and angiotensin receptor-neprilysin inhibitors |
|
|
617 | (8) |
|
|
50 P-Adrenoreceptor Antagonists |
|
|
625 | (12) |
|
|
|
|
51 Sodium-glucose co-transporter-2 inhibitors |
|
|
637 | (8) |
|
|
|
|
52 Mineralocorticoid receptor antagonists |
|
|
645 | (6) |
|
|
|
|
|
651 | (10) |
|
|
|
|
661 | (8) |
|
|
|
669 | (14) |
|
|
56 Problems with polypharmacy, alternative therapies and medication adherence |
|
|
683 | (12) |
|
|
|
SECTION 12 Non-pharmological management |
|
|
|
57 Cardiac rehabilitation and chronic heart failure |
|
|
695 | (12) |
|
|
|
58 Non-pharmacological management |
|
|
707 | (10) |
|
|
SECTION 13 Device therapy for heart failure |
|
|
|
59 Implantable cardioverter-defibrillators |
|
|
717 | (20) |
|
|
|
60 Cardiac resynchronization therapy |
|
|
737 | (22) |
|
|
|
SECTION 14 Surgical therapy for heart failure |
|
|
|
|
759 | (16) |
|
|
|
|
|
|
62 Revascularization, remodelling, and mitral valve surgery |
|
|
775 | (10) |
|
|
63 Mechanical circulatory support |
|
|
785 | (14) |
|
|
SECTION 15 Disease management |
|
|
|
64 Multidisciplinary heart failure management programmes |
|
|
799 | (10) |
|
|
|
|
809 | (10) |
|
|
|
819 | (14) |
|
|
|
|
67 Quality improvement in heart failure |
|
|
833 | (8) |
|
|
|
|
68 Reparative therapies for the failing heart |
|
|
841 | (10) |
|
|
|
|
851 | (8) |
|
|
|
Index |
|
859 | |